Deep brain stimulation in the therapy of advanced Parkinson's disease;Tiefe hirnstimulation bei fortgeschrittener Parkinson-erkrankung

Nervenheilkunde

Volumn 26, Issue 4, 2007, Pages 251-255

  Deuschl, G ^a   Franke, S ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Deep brain stimulation; Parkinson's disease; PDQ 39; Quality of life

Indexed keywords

LEVODOPA;

BRAIN DEPTH STIMULATION; BRAIN HEMATOMA; CLINICAL TRIAL; CONTROL GROUP; DAILY LIFE ACTIVITY; DYSKINESIA; EMOTION; HUMAN; IMMOBILIZATION; MOBILIZATION; MOTOR DYSFUNCTION; NERVE STIMULATION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PNEUMONIA; PSYCHOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SAFETY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STIGMA; THERAPY EFFECT; UNIVERSITY HOSPITAL; WELLBEING;

EID: 34347328107     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1626850     Document Type: Review

References (14)

1. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345(13): 956-963.
2. Limousin P, Krack P, Pollak P et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339(16): 1105-1111.
3. Krack P, Batir A, Van Blercom N et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349(20): 1925-1934.
4. Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 Suppl 14: 290-304.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55(3): 181-184.
6. Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
7. Oertel W, Deuschl G, Eggert K et al. Parkinson-Syndrom. In: Diener HC (Hrsg). Leitlinien der Deutschen Gesellschaft für Neurologie, 3. Auflage. Stuttgart: Thieme Verlag 2003.
8. Berger K, Broll S, Winckelmann J et al. Untersuchung zur Reliabilität der deutschen Version des PDQ-39: Ein krankheitsspezifischer Fragebogen zur Erfassung der Lebensqualität von Parkinson-Patienten. Akt Neurologie 1999; 26: 180-184.
9. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4(3): 241-248.
10. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds). Recent developments in Parkinson's disease. Florham Park, N.J. MacMillan Health Care Information 1987; 153-163.
11. Marconi R, Lefebvre CD, Bonnet AM, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord 1994; 9(1): 2-12.
12. Matthis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karatsu T (eds). New York: Grune and Stratton 1976; 77-121.
13. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
14. Flemenbaum A, Zimmermann RL. Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 1973; 32(3): 783-792.